These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 23773450
1. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma? Barber NA, Loberiza FR, Perry AM, Bast M, Holdeman KP, Esfahane AB, Weisenburger DD, Vose J, Bierman P, Armitage JO, Bociek RG. Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450 [Abstract] [Full Text] [Related]
2. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma]. Liu YH, Zhuang HG, Lin HL, Wu QL, Luo DL, Li L, Luo XL. Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292 [Abstract] [Full Text] [Related]
3. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Boudová L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S, Diehl V, Müller-Hermelink HK, Rüdiger T. Blood; 2003 Nov 15; 102(10):3753-8. PubMed ID: 12881319 [Abstract] [Full Text] [Related]
4. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma. Wu D, Thomas A, Fromm JR. Cytometry B Clin Cytom; 2016 Sep 15; 90(5):424-32. PubMed ID: 26084540 [Abstract] [Full Text] [Related]
5. The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma. Kosari F, Bakhshi T, Ameli F, Mokhtari M. BMC Cancer; 2022 Dec 28; 22(1):1359. PubMed ID: 36577979 [Abstract] [Full Text] [Related]
10. Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications. Harris NL. Mod Pathol; 2013 Jan 28; 26 Suppl 1():S57-70. PubMed ID: 23281436 [Abstract] [Full Text] [Related]
11. Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma. Hartmann S, Eichenauer DA. Pathology; 2020 Jan 28; 52(1):142-153. PubMed ID: 31785822 [Abstract] [Full Text] [Related]
12. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma. Cho BB, Kelting SM, Gru AA, LeGallo RD, Pramoonjago P, Goldin TA, Heitz CT, Aguilera NS. Ann Diagn Pathol; 2017 Feb 28; 26():10-15. PubMed ID: 28038705 [Abstract] [Full Text] [Related]
14. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center. Menke JR, Spinner MA, Natkunam Y, Warnke RA, Advani RH, Gratzinger DA. Arch Pathol Lab Med; 2021 Jun 01; 145(6):753-758. PubMed ID: 32991677 [Abstract] [Full Text] [Related]